GR81966B - - Google Patents

Info

Publication number
GR81966B
GR81966B GR74533A GR840174533A GR81966B GR 81966 B GR81966 B GR 81966B GR 74533 A GR74533 A GR 74533A GR 840174533 A GR840174533 A GR 840174533A GR 81966 B GR81966 B GR 81966B
Authority
GR
Greece
Prior art keywords
dimethylglycine
sarcosine
exerts
glycine
gamma
Prior art date
Application number
GR74533A
Other languages
Greek (el)
English (en)
Inventor
Nikolaus Seiler
Shakir Sarhan
Original Assignee
Merrell Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Pharma Inc filed Critical Merrell Pharma Inc
Publication of GR81966B publication Critical patent/GR81966B/el

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
GR74533A 1983-04-29 1984-04-27 GR81966B (member.php)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB838311804A GB8311804D0 (en) 1983-04-29 1983-04-29 Treatment of seizure disorders and pharmaceutical compositions

Publications (1)

Publication Number Publication Date
GR81966B true GR81966B (member.php) 1984-12-12

Family

ID=10541938

Family Applications (1)

Application Number Title Priority Date Filing Date
GR74533A GR81966B (member.php) 1983-04-29 1984-04-27

Country Status (15)

Country Link
US (1) US4540582A (member.php)
EP (1) EP0124091B1 (member.php)
JP (1) JPS59206309A (member.php)
AT (1) ATE48759T1 (member.php)
AU (1) AU563291B2 (member.php)
CA (1) CA1228818A (member.php)
DE (1) DE3480764D1 (member.php)
DK (1) DK160805C (member.php)
GB (2) GB8311804D0 (member.php)
GR (1) GR81966B (member.php)
IE (1) IE57286B1 (member.php)
IL (1) IL71650A (member.php)
NZ (1) NZ207962A (member.php)
PT (1) PT78492B (member.php)
ZA (1) ZA843032B (member.php)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1192892A (en) * 1992-01-10 1993-08-03 Natalya Mikhailovna Burbenskaya Pharmaceutical preparation of antistress, stress-preventive and nootropic action
CA2327285C (en) * 1998-05-15 2005-06-14 Warner-Lambert Company Stabilized pharmaceutical preparations of gamma-aminobutyric acid derivatives and process for preparing the same
US6890951B2 (en) 1998-08-05 2005-05-10 Brookhaven Science Associates Llc Treatment of addiction and addiction-related behavior
US6057368A (en) * 1998-08-05 2000-05-02 Brookhaven Science Associates Llc Treatment of addiction and addiction-related behavior
US6541520B1 (en) 1998-08-05 2003-04-01 Brookhaven Science Associates Treatment of addiction and addiction-related behavior
US6395783B1 (en) 2000-10-23 2002-05-28 Brookhaven Science Associates, Llc Treatment of PCP addiction and PCP addiction-related behavior
US6713497B1 (en) * 2003-03-17 2004-03-30 Brookhaven Science Associates, Llc Use of vitamin B6 to mitigate visual field defects associated with the use of GABAergic drugs in mammals
US20090017047A1 (en) * 2004-06-11 2009-01-15 Egon Tech Preparation for the Prevention and Treatment of Stress Conditions as Well as Functional and Organic Disorders of the Nervous System and Metabolic Disorders
RU2007130941A (ru) * 2005-01-14 2009-02-20 Н.В. Органон (Nl) Ингибиторы повторного поглощения глицина для лечения зависимости от наркотиков и алкоголя
US20160151316A1 (en) * 2012-01-27 2016-06-02 Catalyst Pharmaceutical Partners Method of treating tourette's disorder with gaba-aminotransferase inactivators
US10226442B2 (en) * 2017-07-10 2019-03-12 Syneurx International (Taiwan) Corp. Lithium salts of N-substituted glycine compounds and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1111433A (en) * 1965-08-25 1968-04-24 Zoja Lab Chim Farm A method to potentiate the activity of a group of sedative,hypnotic and narcotic compositions
US3960927A (en) * 1975-03-18 1976-06-01 Richardson-Merrell Inc. Olefinic derivatives of amino acids
FR2437834A1 (fr) * 1978-10-04 1980-04-30 Lejeune Jerome Compositions pharmaceutiques a base de l-serine ou de glycine
GB2120244B (en) * 1982-05-17 1985-05-01 Merrell Toraude & Co Aminoalkadiene derivative

Also Published As

Publication number Publication date
US4540582A (en) 1985-09-10
PT78492A (en) 1984-05-01
IE841048L (en) 1984-10-29
DK213484A (da) 1984-10-30
DK213484D0 (da) 1984-04-27
AU2644384A (en) 1984-11-01
GB2138680A (en) 1984-10-31
ATE48759T1 (de) 1990-01-15
IL71650A0 (en) 1984-07-31
GB2138680B (en) 1986-05-21
EP0124091A3 (en) 1987-10-07
DK160805C (da) 1991-10-07
EP0124091A2 (en) 1984-11-07
EP0124091B1 (en) 1989-12-20
DK160805B (da) 1991-04-22
GB8311804D0 (en) 1983-06-02
NZ207962A (en) 1986-12-05
JPS59206309A (ja) 1984-11-22
AU563291B2 (en) 1987-07-02
ZA843032B (en) 1984-11-28
IE57286B1 (en) 1992-07-15
DE3480764D1 (de) 1990-01-25
PT78492B (en) 1986-06-11
JPH0527606B2 (member.php) 1993-04-21
GB8410504D0 (en) 1984-05-31
CA1228818A (en) 1987-11-03
IL71650A (en) 1988-07-31

Similar Documents

Publication Publication Date Title
BR9610838A (pt) Processo para tratar um indivìduo tendo uma condição patológica envolvendo neovascularização.
ES520340A0 (es) Un procedimiento para la preparacion de diarilpirazinas o triazinas.
PL324330A1 (en) Do- and trivalent low-molecule selectin inhibitors
GB2138680B (en) Treatment of seizure disorders
AU1587083A (en) Engine shutdown valve
GB8325749D0 (en) Pressure regulating valve
GB2135390B (en) Valve disabling system for i c engine
IL132709A0 (en) Use of gaba analogs such as gabapentin in the manufacture of a medicament for treating inflammatory diseases
AU1687383A (en) I.c. engine valve actuating apparatus
IE821172L (en) Anticonvulsant benzamides
GB2140083B (en) Driving i.c. engine fuel pump and distributor
GB2145152B (en) Rotary valve i.c. engine
GB8327188D0 (en) Delivery-regulation unit for in-line injection pumps
GB2125944B (en) Regulating valve
GB2123116B (en) Injection pump camshaft
EP0155934A4 (en) Pharmaceutical compositions for the treatment of disorders caused by human drugs.
AU538787B2 (en) Muffler for i.c. engine
MY116362A (en) Use of selegiline for the treatment of epileptic disorders
JPS5311251A (en) Running valve oil system
GB2117045B (en) I.c. engine carburettor
US4916140B1 (member.php)
GB2120733B (en) Valve system for pumps
EP0092869A3 (en) Improved motor
GB2159486B (en) Supplying components, e.g. valve seats, from a source to an assembly point
MX9803172A (es) Utilizacion de 2-amino-4-(4-fluorobencilamino)-1-etoxicarbonilaminobenceno para la profilaxis y el tratamiento de las consecuencias del deficit agudo y cronico de la irrigacion sanguinea cerebral, como tambien de enfermedades neurodegenerativas.